| Date | Title | Description |
| 03.12.2025 | Okami Medical Secures $45M, Names New CEO for Growth | Okami Medical, a vascular tech firm, closed a $45M round. The funding will fuel expansion and innovation. Drew Hykes, ex-Inari Medical CEO, now leads Okami. Gilde Healthcare led the round, joining the board.
Okami Medical, a California-base... |
| 01.12.2025 | Okami Medical: $45 Million In New Funding Raised And New CEO Appointed | Okami Medical has closed an oversubscribed $45 million financing round led by new investor Gilde Healthcare, with participation from existing backers Vensana Capital and U.S. Venture Partners. The company plans to deploy the capital to expa... |
| 04.09.2025 | MedTech M&A Surges in 2025: Why Startups Are Now Ripe for Acquisition | After a few mixed years in medical technology (MedTech) mergers and acquisition (M&A) activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A ... |
| 06.01.2025 | Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment | Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common s... |
| 23.08.2024 | Clot Removal Device Correction: Inari Medical Updates Use Instructions for ClotTriever XL Catheter due to Reports of Patient Injury and Death from Device Entrapment and Pulmonary Emboli | This recall involves updating instructions for using the ClotTriever XL, 30mm device, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. Affected Product
Product... |
| 20.06.2024 | NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit | NEW YORK, June 20, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (... |
| 28.05.2024 | ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI | NEW YORK, May 28, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (t... |
| 14.05.2024 | ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI | NEW YORK, May 14, 2024 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24,... |
| 12.03.2024 | Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry | Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials
IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inar... |
| 12.03.2024 | Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry | - |
| 11.03.2024 | ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI | NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical, Inc. (NASDAQ: NARI) resulting from allegat... |
| 11.03.2024 | NARI ALERT: Kessler Topaz Meltzer & Check, LLP Encourages Inari Medical, Inc. (NASDAQ: NARI) Investors with Significant Losses to Contact the Firm | RADNOR, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inari Medical, In... |
| 11.03.2024 | ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI | - |
| 11.03.2024 | NARI ALERT: Kessler Topaz Meltzer & Check, LLP Encourages Inari Medical, Inc. (NASDAQ: NARI) Investors with Significant Losses to Contact the Firm | - |
| 08.03.2024 | Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm | - |
| 07.03.2024 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inari Medical, Inc.- NARI | - |
| 06.03.2024 | NARI 投資者通告：全球頂尖法律顧問 ROSEN 鼓勵 Inari Medical, Inc. 投資者查詢證券集體訴訟調查狀況 – NARI | - |
| 05.03.2024 | NARI INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI | - |
| 04.03.2024 | NARI Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Inari Medical, Inc. (NASDAQ: NARI) Investors with Significant Losses to Contact the Firm | RADNOR, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inari Medical, In... |
| 01.11.2023 |
Inari Medical plans to buy LimFlow Medical for up to $415M | The LimFlow System for Transcatheter Arterialization of Deep Veins diverts blood from a diseased tibial artery to a tibial vein to deliver oxygen to a patient’s ischemic foot. [Illustration courtesy of LimFlow]Inari Medical (NASDAQ: NARI) +... |
| 05.08.2022 | Inari Medical to promote COO into CEO spot | Inari Medical COO Drew Hykes will become CEO. [Image courtesy of Inari Medical]Inari Medical (Nasdaq:NARI) announced this week that Drew Hykes will succeed Bill Hoffman as the company’s CEO.
Hykes, who currently serves as COO at the venous-... |
| 11.03.2022 | Inari Medical to bring in up to $186.3M in stock offering | Inari Medical (Nasdaq:NARI) announced that it priced an underwritten public offering worth up to $186.3 million in proceeds.
Irvine, California-based Inari Medical’s offering includes 2 million shares of its common stock at a public offerin... |
| 10.11.2021 | Inari Medical Reports Third Quarter 2021 Financial Results - Form 8-K | Inari Medical Reports Third Quarter 2021 Financial Results
IRVINE, CALIFORNIA - November 9, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company focused on developing products to treat an... |
| 27.05.2020 | Inari Medical IPO Raises $156 million | Inari Medical debuted on the NASDAQ on May 22, pricing at $19 per share, above its previously upsized range of $17-$18 per share. The IPO raised nearly $156 million, and market cap at the time of this writing is around $2 billion.
Share va... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries.
Medical device companies, for example, raised $2.9... |
| 03.04.2018 | Gilde Healthcare leads USD 27 million financing round of innovative catheter company Inari Medical | Irvine, US - Inari Medical, Inc., announced the close of a Series C financing totaling $27.0 million. The financing was led by new investor Gilde Healthcare and was joined by Versant Ventures and U.S. Venture Partners. Geoff Pardo of Gilde ... |
| 29.03.2018 | Inari Medical Raises $27M in Series C Financing | Inari Medical, Inc., an Irvine, CA-based medical device company, raised $27.0m in Series C financing.
The round was led by new investor Gilde Healthcare with participation from existing investors Versant Ventures and U.S. Venture Partners. ... |
| 29.03.2018 | Inari Medical Announces Completion of $27 Million Series C Financing | - |
| 30.06.2015 | Inari Medical Raises $12.4M |
IRVINE, CA, Inari Medical, Inc. announced today that it has closed a $12.4 million Series B venture capital financing.
>> Click here for more funding data on Inari Medical
>> To export Inari Medical funding data to PDF and E... |
| 30.06.2015 | Inari Medical Closes $12.4M Series B Financing | Inari Medical, Inc., an Irvine, CA-based medical device company, closed a $12.4m Series B venture capital financing round.
Backers included members of the board of directors, returning investors Versant Ventures and US Venture Partners and ... |
| 30.06.2015 |
Inari Medical Finds $12.4M
| Irvine-based medical device developer Inari Medical has raised $12.4M in a Series B funding, the company announced this morning, for its efforts to develop medical devices for the vascular thrombus and emboli. The funding came from Versant ... |
| 17.10.2013 |
Inari Medical Gets $4.7M For Medical Device Startup
| Aliso Viejo-based Inari Medical, a medical device developer incubated out of Inceptus Medical, said Wednesday that it has raised $4.7M in a Series A funding round. The funding came from Versant Venturs and U.S. Venture Partners. Inceptus sa... |
